Recombinant multi-species Ferritin light chain/FTL protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Ferritin light chain/FTL protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes the light subunit of the ferritin protein. Ferritin is the major intracellular iron storage protein in prokaryotes and eukaryotes. It is composed of 24 subunits of the heavy and light ferritin chains. Variation in ferritin subunit composition may affect the rates of iron uptake and release in different tissues. A major function of ferritin is the storage of iron in a soluble and nontoxic state. Defects in this light chain ferritin gene are associated with several neurodegenerative diseases and hyperferritinemia-cataract syndrome. This gene has multiple pseudogenes. [provided by RefSeq, Jul 2008]
The Alternative Names of target: FT,FTL,FTL1,Ferritin L subunit,Ferritin light chain,Ftl,Ftl-1,Ftl1,L-ferritin,LFTD,NBIA3

Target products collectionGo to Ferritin light chain/FTL products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP7007-Ag-1/ GM-Tg-hg-IP7007-Ag-2 Human Ferritin light chain/FTL protein Human
GM-Tg-rg-IP7007-Ag-1/ GM-Tg-rg-IP7007-Ag-2 Rat Ferritin light chain/FTL protein Rat
GM-Tg-mg-IP7007-Ag-1/ GM-Tg-mg-IP7007-Ag-2 Mouse Ferritin light chain/FTL protein Mouse
GM-Tg-cynog-IP7007-Ag-1/ GM-Tg-cynog-IP7007-Ag-2 Cynomolgus/Rhesus macaque Ferritin light chain/FTL protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP7007-Ag-1/ GM-Tg-felg-IP7007-Ag-2 Feline Ferritin light chain/FTL protein Feline
GM-Tg-cang-IP7007-Ag-1/ GM-Tg-cang-IP7007-Ag-2 Canine Ferritin light chain/FTL protein Canine
GM-Tg-bovg-IP7007-Ag-1/ GM-Tg-bovg-IP7007-Ag-2 Bovine Ferritin light chain/FTL protein Bovine
GM-Tg-equg-IP7007-Ag-1/ GM-Tg-equg-IP7007-Ag-2 Equine Ferritin light chain/FTL protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP7007-Ag-1/ GM-Tg-hg-IP7007-Ag-2; GM-Tg-rg-IP7007-Ag-1/ GM-Tg-rg-IP7007-Ag-2;
GM-Tg-mg-IP7007-Ag-1/ GM-Tg-mg-IP7007-Ag-2; GM-Tg-cynog-IP7007-Ag-1/ GM-Tg-cynog-IP7007-Ag-2;
GM-Tg-felg-IP7007-Ag-1/ GM-Tg-felg-IP7007-Ag-2; GM-Tg-cang-IP7007-Ag-1/ GM-Tg-cang-IP7007-Ag-2;
GM-Tg-bovg-IP7007-Ag-1/ GM-Tg-bovg-IP7007-Ag-2; GM-Tg-equg-IP7007-Ag-1/ GM-Tg-equg-IP7007-Ag-2
Products Name Ferritin light chain/FTL protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Ferritin light chain/FTL
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Ferritin light chain/FTL protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.